Search

Your search keyword '"J. Stoevesandt"' showing total 83 results

Search Constraints

Start Over You searched for: Author "J. Stoevesandt" Remove constraint Author: "J. Stoevesandt"
83 results on '"J. Stoevesandt"'

Search Results

1. Bienen- und Wespengiftallergie in verschiedenen Lebensphasen

2. Therapieresistente purulente Papeln und Knoten gluteal und im Bereich beider Oberschenkel

3. ILDS Newsletter No. 24

4. Dithiols as chelators : A cause of bullous skin reactions

5. A novel missense mutation in GJB2 disturbs gap junction protein transport and causes focal palmoplantar keratoderma with deafness

6. Relief of photoallergy: atorvastatin replacing simvastatin

7. [Therapy-resistant purulent papules and nodes on both buttocks and thighs]

9. Distribution of the meningococcal insertion sequence IS1301 in clonal lineages of Neisseria meningitidis

10. Adjuvant treatment of recalcitrant bullous pemphigoid with immunoadsorption

11. Lethal junctional epidermolysis bullosa with pyloric atresia due to compound heterozygosity for two novel mutations in the integrin β4 gene

12. [Dithiols as chelators. A cause of bullous skin reactions]

13. Genetic isolation of meningococci of the electrophoretic type 37 complex

14. Bee/Vespula Venom-Specific IgE Ratio Greater Than 5:1 Indicates Culprit Insect in Double-Sensitized Patients.

15. VEXAS-Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestations.

17. Influencing factors on the safety and effectiveness of venom immunotherapy.

18. Delayed-Type Heparin Allergy: Intravenous Tolerance Despite Inflammatory Skin Reaction After Subcutaneous Injection.

21. Disease-related burden and long-term outcome in orofacial granulomatosis: observations from a large single-centre cohort.

22. FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus.

24. Outcome of a de-labelling algorithm compared with results of penicillin (β-lactam) allergy testing.

25. Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial.

27. Metastatic Crohn's disease: an underestimated entity.

28. β-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy.

29. Neutropenia resulting from high-dose intravenous immunoglobulin in dermatological patients.

31. Predominant patterns of β-lactam hypersensitivity in a single German Allergy Center: exanthem induced by aminopenicillins, anaphylaxis by cephalosporins.

34. Metamizole-induced reactions as a paradigm of drug hypersensitivity: Non-allergic reactions, anaphylaxis, and delayed-type allergy.

35. Immunizations in immunocompromised patients: a guide for dermatologists.

38. Risk factors and indicators of severe systemic insect sting reactions.

39. [Scabies in old age].

40. Radiocontrast Media Hypersensitivity: Skin Testing Differentiates Allergy From Nonallergic Reactions and Identifies a Safe Alternative as Proven by Intravenous Provocation.

42. Differential diagnosis of late-type reactions to injected local anaesthetics: Inflammation at the injection site is the only indicator of allergic hypersensitivity.

43. Sensitization to Hymenoptera venom marker allergens: Prevalence, predisposing factors, and clinical implications.

44. Twenty Years' Experience with Anaphylaxis-Like Reactions to Local Anesthetics: Genuine Allergy is Rare.

45. Freshly squeezed: anaphylaxis caused by drone larvae juice.

46. Structured Diagnostic Approach and Risk Assessment in Mucous Membrane Pemphigoid with Oesophageal Involvement.

47. "Treating Through" Decision and Follow-up in Antibiotic Therapy-Associated Exanthemas.

48. Anti-desmoglein 1 IgG/IgA pemphigus associated with thymoma.

49. Safety of 100 µg venom immunotherapy rush protocols in children compared to adults.

50. Reply.

Catalog

Books, media, physical & digital resources